Baseline characteristics
| Characteristics | Usual care group (n=56) | App user group* (n=107) | Total (n=163) |
| Demographics | |||
| Age, years, mean (SD) | 56.8 (8.64) | 58.4 (9.04) | 57.9 (8.91) |
| Male, N/total (%) | 50/56 (89.3) | 93/107 (86.9) | 143/163 (87.7) |
| Ethnicity, N/total (%) | |||
| Caucasian | 27/56 (48.2) | 57/107 (53.3) | 84/163 (51.5) |
| Asian/Southeast Asian | 21/56 (37.6) | 34/107 (31.8) | 55/163 (33.7) |
| Other | 8/56 (14.2) | 16/107 (14.9) | 24/163 (14.7) |
| Risk factors | |||
| Hypertension, N/total (%) | 29/56 (51.8) | 67/107 (62.6) | 96/163 (58.9) |
| Diabetes, N/total (%) | 18/56 (32.1) | 37/107 (34.6) | 55/163 (33.7) |
| Dyslipidaemia, N/total (%) | 38/56 (67.9) | 76/107 (71.0) | 114/163 (69.9) |
| Clinical data, mean (SD) | |||
| BMI, kg/m2 | 27.7 (4.52) | 28.6 (5.29) | 28.3 (5.04) |
| Total cholesterol, mmol/L | 4.1 (1.17) | 4.1 (1.12) | 4.1 (1.13) |
| LDL cholesterol, mmol/L | 2.2 (0.94) | 2.2 (0.99) | 2.2 (0.97) |
| Systolic BP, mm Hg | 124.4 (20.17) | 125.9 (17.32) | 125.3 (18.30) |
| Diastolic BP, mm Hg | 78.9 (11.42) | 80.3 (10.51) | 79.8 (10.81) |
| Medications | |||
| Aspirin or other antiplatelet agents, N/total (%) | 52/56 (92.9) | 102/107 (95.3) | 154/163 (94.5) |
| ACE inhibitor/ARB, N/total (%) | 38/56 (67.9) | 69/107 (64.5) | 107/163 (65.6) |
| Beta-blockers, N/total (%) | 43/56 (76.8) | 70/107 (65.4) | 113/163 (69.3) |
| Statins, N/total (%) | 53/56 (94.6) | 100/107 (93.5) | 153/163 (93.9) |
| All four medications above, N/total (%) | 22/56 (39.3) | 45/017 (42.1) | 67/163 (41.1) |
| Number of CV medications, median (IQR) | 4.0 (4.0;5.0) | 4.0 (3.0;5.0) | 4.0 (4.0;6.0) |
| Number of CV+other medications, median (IQR) | 5.0 (4.0;6.0) | 5.0 (4.0;6.0) | 5.0 (4.0;6.0) |
| Medication adherence | |||
| MMAS-8, mean (SD) | 7.0 (1.29) | 6.8 (1.40) | 6.8 (1.36) |
| Levels of adherence, N/total (%) | |||
| Low adherence (MMAS score <6)11 | 11/56 (19.6) | 28/107 (26.2) | 39/163 (23.9) |
| Medium adherence (MMAS score 6–<8)11 | 20/56 (35.7) | 37/107 (34.6) | 57/163 (35.0) |
| High adherence (MMAS score=8)11 | 25/56 (44.6) | 42/107 (39.3) | 67/163 (41.1) |
Use of the MMAS is protected by US copyright laws. A licence agreement to use the scale was obtained from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90 095–1772, dmorisky@gmail.com.
*App user group includes basic and advanced app users.
ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CV, cardiovascular; LDL, low-density lipoprotein; MMAS-8, 8-item Morisky Medication Adherence Scale.